Literature DB >> 33172541

Finding the right balance between efficacy and tolerability for TB treatment.

M K Haas1, E H Ignatius2, J E Stout3, K E Dooley2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33172541      PMCID： PMC9190188          DOI： 10.5588/ijtld.20.0502

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   3.427


× No keyword cloud information.
  1 in total

1.  First-line tuberculosis treatment with double-dose rifampicin is well tolerated.

Authors:  A K J Maug; M A Hossain; M Gumusboga; T Decroo; W Mulders; S Braet; J Buyze; D Arango; C Schurmans; N Herssens; T Demeulenaere; L Lynen; B C de Jong; A Van Deun
Journal:  Int J Tuberc Lung Dis       Date:  2020-05-01       Impact factor: 2.373
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.